Skip to content

PHLV

Active
Private limited companyfounded 2023active for 3 yearsSint-Amandsesteenweg(BOR) 212, 2880 Bornem, BelgiumKBO/BCE: BE 0803.696.369
Summary

The computed 12-month bankruptcy probability of PHLV is 2.0% (moderate). The 2025 annual accounts show negative equity (-€56,671) and a net result of -€54,664. Its solvency ranks better than 17% of 22,679 sector peers (NACE 47, financial year 2025). The company has been active since 2023 and the Belgian Official Gazette contains no insolvency or warning signals.

Overview

Activity
Retail sale of pharmaceutical products
NACE 47730
1 site
Size
€363,992total assets 2025
Equity
-€56,671
Loss
-€54,664
Turnover not published (abbreviated or micro format)
Financial health
52 Fair Checked score 2025
Bankruptcy probabilitywithin 12 months
2.0%
Structure
  • LEFEBURE Vincent Willy MilouDirector
2025 accounts 35 days early
Why 52raises riskSector: Retail trade (NACE 47)Loss of €54,664, the second in a row (financial year 2025)Negative equity -€56,671lowers riskSize: total assets €363,992Show the evidence

Checked score

Score 2025
52 / 100
Fair
Probability in this band: 1.5% to 4.2%
Financially better than 15% of its sector peers (NACE 47, micro)
Financial strength · tick = 2024
Weak
Solvency 9-13
equity -15.6% of total assets
Liquidity 39+4
short-term debt 29.7% · cash 1.1%
Profitability 0=
return on assets -15.0%
Bankruptcy probability, 12 months
2.0% Moderate
0%0.5%1.5%4%10%≥ 25%

About 2 in 100 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.6% (40,268 companies, NACE 47, micro)
Last 24 months 11-2024: 4.4% 12-2024: 4.9%▲ +0.5 percentage points vs 11-2024 01-2025: 4.9%● unchanged vs 12-2024 02-2025: 5.1%▲ +0.2 percentage points vs 01-2025 03-2025: 5.2%▲ +0.1 percentage points vs 02-2025 04-2025: 5.0%▼ -0.2 percentage points vs 03-2025 05-2025: 5.1%▲ +0.1 percentage points vs 04-2025 06-2025: 5.4%▲ +0.3 percentage points vs 05-2025 07-2025: 5.5%▲ +0.1 percentage points vs 06-2025highest value 08-2025: 3.3%▼ -2.2 percentage points vs 07-2025 09-2025: 3.3%● unchanged vs 08-2025 10-2025: 3.3%● unchanged vs 09-2025 11-2025: 3.3%● unchanged vs 10-2025 12-2025: 3.3%● unchanged vs 11-2025 01-2026: 3.3%● unchanged vs 12-2025 02-2026: 3.3%● unchanged vs 01-2026 03-2026: 3.2%▼ -0.1 percentage points vs 02-2026 04-2026: 3.6%▲ +0.4 percentage points vs 03-2026 05-2026: 2.1%▼ -1.5 percentage points vs 04-2026 06-2026: 2.1%● unchanged vs 05-2026 07-2026: 2.1%● unchanged vs 06-2026 08-2026: 2.3%▲ +0.2 percentage points vs 07-2026 09-2026: 2.7%▲ +0.4 percentage points vs 08-2026 10-2026: 2.0%▼ -0.7 percentage points vs 09-2026lowest value
No credit on open account
Liquidity insufficient (current ratio 0.07, compared with 0.25 in 2024, below 1; short-term debt: 29.7% and cash: 1.1% of total assets), and equity is negative.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro): better than 15% on solvency, 37% on liquidity, 6% on profitability and 1% on growth.

The bankruptcy probability was computed on 30-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Six signals.
lowers riskraises riskneutral
lowers risk · Size: total assets €363,992
Companies of this size fail less often; how much that weighs depends on the rest of its profile.
NBB · annual accounts
raises risk · Sector: Retail trade (NACE 47)
KBO
raises risk · Loss of €54,664, the second in a row (financial year 2025)
NBB · annual accounts
raises risk · Negative equity -€56,671
NBB · annual accounts
raises risk · Negative equity
The 2025 annual accounts show negative equity and a net loss.
NBB · annual accounts 2025
Equity per financial year
2425
2024 to 2025 · latest year -€56,671
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 26-06-2026, 35 days ahead of the deadline.
NBB · 2 filings
Deviation from the deadline
2025
35 days early
2024
16 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 2 accounts on average 26 days before the deadline; the sector median (NACE 47) for financial year 2024 is on the deadline day, and 47% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Where today falls in the filing period
31-10-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since incorporation in 2023.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · micro…
  2. Annual accounts filedfinancial year 2024 · abbreviated…
  3. Registered officeRegistered-office move

Financials · financial year 2025, micro format

Equity
-€56,671▼ 2,725%
2024 · -€2,006
Total assets
€363,992▲ 456%
2024 · €65,504
Net result
-€54,664▼ 102%
2024 · -€27,006
Working capital
-€100,126▼ 215%
2024 · -€31,793
Trend over the years

2024 to 2025, 2 financial years

The operating result stays negative: a loss of €51,309 in 2025 against €26,280 in 2024; the loss grows.

What the company sold each financial year and what was left of it. A loss stands below the zero line.

Operating result-€51,309 2025 Net result-€54,664 2025

Use the arrow keys on the chart for the figures per year.

Sector: the middle half of NACE 47, Retail trade: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30. Dashed line: the median. Available for Net result, Equity, Total assets, Working capital, Solvency, Current ratio, Return on assets (ROA).

Every figure with its change against the financial year before
favourable unfavourable
Line20242025
Operating result-€26,280--€51,309▼ 95.2%
Net result-€27,006below the sector's middle half--€54,664below the sector's middle half▼ 102%
Equity-€2,006below the sector's middle half--€56,671below the sector's middle half▼ 2,725%
Total assets€65,504below the sector's middle half-€363,992above the sector's middle half▲ 456%
Debt€67,510-€420,663▲ 523%
Working capital-€31,793below the sector's middle half--€100,126below the sector's middle half▼ 215%
Solvency-3.1%below the sector's middle half--15.6%below the sector's middle half▼ 12.5pp
Current ratio0.25below the sector's middle half-0.07below the sector's middle half▼ 0.18
Return on assets (ROA)-41.2%below the sector's middle half--15.0%below the sector's middle half▲ 26.2pp
Staff (FTE)0below the sector's middle half-
above within below the middle half of NACE 47, Retail trade: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30.
Turnover and EBIT margin not published: the abbreviated or micro format does not require them.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €363,992
Fixed assets €356,050 ▲ 550%
Current assets €7,942 ▼ 25.9%
Equity and liabilities
Equity-€56,671
Debt€420,663
Equity is negative: debt (€420,663) exceeds the balance-sheet total (€363,992).
Key figures and ratios
2025 value · change against 2024
EBITDA
-€15,008▲
2024 · -€22,067
Cash flow
-€18,363▲
2024 · -€22,793
Interest coverage
-4.41▲
2024 · -29.68
Debt ≤ 1 year
€108,069▲
2024 · €42,510
Debt > 1 year
€312,594▲
2024 · €25,000
No debt to equity: equity is negative, so debt divided by equity means nothing.
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.

Peer companies

Historical observation

Of the 7,639 companies that looked in July 2024 the way this one looks now, 8.8% went bankrupt within 24 months and 84.9% are still going.

  • Micro
  • 2 to 5 years old
  • negative equity
  • a loss of 10% of the balance sheet or more
8.8% went bankrupt
5.6% stopped otherwise
84.9% still going

A further 0.7% stopped, but we cannot tell whether within those 24 months.

For this company itself Checked computes a bankruptcy probability of 2.0% over twelve months; the group does not contradict it.

How reliable is this rule?

Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,445 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.

The companies in ten equal groups, from lowest to highest expected share.
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 3.0% 3.1%
10 5.6% 6.2%

The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74.5% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.

An observation about 7,639 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.

Annual accounts
Filed annual accounts As filed with the NBB · 2025 against 2024 · 35 lines
Balance sheet Code20242025
Assets
Total assets20/58€65,504€363,992▲
Fixed assets21/28€54,787€356,050▲
Intangible fixed assets21€25,787€22,787▼
Tangible fixed assets22/27€29,000€333,263▲
Land and buildings22€29,000€333,263▲
Current assets29/58€10,717€7,942▼
Amounts receivable within one year40/41€718€3,862▲
Other amounts receivable41€718€3,862▲
Cash at bank and in hand54/58€9,999€4,081▼
Equity and liabilities
Total equity and liabilities10/49€65,504€363,992▲
Equity10/15-€2,006-€56,671▼
Contributions10/11€25,000€25,000=
Profit (loss) carried forward14-€27,006-€81,671▼
Amounts payable17/49€67,510€420,663▲
Amounts payable after more than one year17€25,000€312,594▲
Financial debts170/4€25,000€312,594▲
Amounts payable within one year42/48€42,510€108,069▲
Current portion of amounts payable after more than one year42-€10,664
Trade debts44-€30,000
Suppliers440/4-€30,000
Other amounts payable47/48€42,510€67,405▲
Income statement Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€4,213€36,301▲
Other operating charges640/8€264€1,520▲
Gross operating margin9900-€21,802-€13,488▲
Operating profit (loss)9901-€26,280-€51,309▼
Financial income75/76B€17€49▲
Recurring financial income75€17€49▲
Financial charges65/66B€743€3,404▲
Recurring financial charges65€743€3,404▲
Profit (loss) for the period before taxes9903-€27,006-€54,664▼
Profit (loss) for the period9904-€27,006-€54,664▼
Profit (loss) for the period to be appropriated9905-€27,006-€54,664▼
Appropriation of the result
Profit (loss) to be appropriated9906-€27,006-€81,671▼
Profit (loss) brought forward from the previous period14P--€27,006
Social balance sheet
Average headcount (FTE)90870.0-

The notes to these accounts (10 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line20242025Change
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€4,213€36,301▲ 762%
Other operating charges640/8€264€1,520▲ 475%
Gross operating margin9900-€21,802-€13,488▲ 38.1%
Operating profit (loss)9901-€26,280-€51,309▼ 95.2%
Financial income75/76B€17€49▲ 192%
Recurring financial income75€17€49▲ 192%
Financial charges65/66B€743€3,404▲ 358%
Recurring financial charges65€743€3,404▲ 358%
Profit (loss) for the period before taxes9903-€27,006-€54,664▼ 102%
Profit (loss) for the period9904-€27,006-€54,664▼ 102%
Profit (loss) for the period to be appropriated9905-€27,006-€54,664▼ 102%
Line20242025Change
Assets
Total assets20/58€65,504€363,992▲ 456%
Fixed assets21/28€54,787€356,050▲ 550%
Intangible fixed assets21€25,787€22,787▼ 11.6%
Tangible fixed assets22/27€29,000€333,263▲ 11×
Land and buildings22€29,000€333,263▲ 11×
Current assets29/58€10,717€7,942▼ 25.9%
Amounts receivable within one year40/41€718€3,862▲ 438%
Other amounts receivable41€718€3,862▲ 438%
Cash at bank and in hand54/58€9,999€4,081▼ 59.2%
Equity and liabilities
Total equity and liabilities10/49€65,504€363,992▲ 456%
Equity10/15-€2,006-€56,671▼ 2,725%
Contributions10/11€25,000€25,000=
Profit (loss) carried forward14-€27,006-€81,671▼ 202%
Amounts payable17/49€67,510€420,663▲ 523%
Amounts payable after more than one year17€25,000€312,594▲ 13×
Financial debts170/4€25,000€312,594▲ 13×
Amounts payable within one year42/48€42,510€108,069▲ 154%
Current portion of amounts payable after more than one year42-€10,664-
Trade debts44-€30,000-
Suppliers440/4-€30,000-
Other amounts payable47/48€42,510€67,405▲ 58.6%
Line20242025Change
Profit (loss) for the period9904-€27,006-€54,664▼ 102%
+ Depreciation and write-downs630€4,213€36,301▲ 762%
Operating cash flow (approximation)-€22,793-€18,363▲ 19.4%
Investment in fixed assets (approximation)--€337,564-
Change in cash--€5,918-

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Filings with the National Bank (2)
Financial year Type Filed Reference
31-12-2025 micro format 26-06-2026 2026-00216862
31-12-2024 abbreviated format 15-07-2025 2025-00279529

Similar companies · same sector and region

This company's figures show no positive equity and no headcount, so a size comparison is not possible. These companies share only the sector and the region. Of the 5,204 active companies whose main activity is retail sale of pharmaceutical products (NACE 47730), figures are known for 3,907. See the whole sector

Public contracts: No European public contracts awarded found since October 2016. Contracts below the EU thresholds are not in TED.

Directors

Directors
1 director, no change since 2023
LEFEBURE Vincent Willy Milou
Statutory director · since 11-07-2023
Current
Derived from published Gazette deeds. The KBO keeps the official list of office holders; we do not read it, so the two can differ. See the directors and other office holders in the KBO →

Mandate history

1 person since 2023, 1 in office
Show
  • Board
Mandates per person, with start and end dates
Name Functions and periods
LEFEBURE Vincent Willy Milou
  • Statutory director, from 11-07-2023 to date
See the board, name and registered office on a given date →

Owners and capital

Capital and shareholders

Shareholders according to the deeds
At incorporation act of 11-07-2023 ↗

The Belgian Official Gazette names shareholders only when an act mentions them; the share register itself is not published.

Capital over the years
  1. 11-07-2023 Incorporation · €25,000 · 250 shares

Group and network

Connections & network

1 current director
Depth

The network starts from this company’s directors. Other companies they run appear here as nodes.

This company Company Director Shareholding +N: links not shown yet Click a node to look further, drag to arrange, zoom with the mouse wheel.

History

On 6 July 2023, PHLV was incorporated as a private limited company by one natural person, with a starting capital of €25,000.12 In 2024 the registered office moved to Bornem.3 LEFEBURE Vincent Willy Milou has served as statutory director of the company since 2023.2

  1. 1KBO register
  2. 2Belgian Official Gazette, 11-07-2023
  3. 3Belgian Official Gazette, 09-04-2024

Acts, filings and financial milestones

Next filing, financial year 2026, expected by 31-07-2027
2026
26-06
NBB filing Annual accounts filed
financial year 2025 · micro format
2025
15-07
NBB filing Annual accounts filed
financial year 2024 · abbreviated format
2024
09-04
Gazette deed Registered office
Registered-office move2 facts ▸
  • Board meeting, 18-03-2024
  • Registered-office move, Sint-Amandsesteenweg 212, 2880 Bornem
2023
11-07
Gazette deed Incorporation
Appointment: LEFEBURE Vincent Willy Milou (statutory director) · Founder · Founding capital7 facts ▸
  • Incorporation, 14-06-2023
  • Founder, LEFEBURE Vincent Willy Milou
  • Founding capital, €25,000
  • Bank account, “BNP Paribas Fortis, vennootschap in oprichting” (deed in Dutch)
  • Director appointment, LEFEBURE Vincent Willy Milou (statutory director)
  • Registered office clause, “3000 Leuven,Brusselsestraat 256 bus 0101” (deed in Dutch)
  • Other provision, “exclusief btw, kosten oprichting ten laste vennootschap” (deed in Dutch)
Gazette deedNBB filing
2 of 2 deeds read

Register details

Identification
Legal formPrivate limited company
Founded06-07-2023
Financial year end31-12
Activities, NACEBEL 2025
47730Retail sale of pharmaceutical products
E-invoicing
Reachable via Peppol
Peppol ID 0208:0803696369
Registered 30-09-2024

If you follow this company, Checked tells you the day it leaves the Peppol register.

Register as of 30 October 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.

Environmental permits: No permit applications found in Flanders. Brussels and Wallonia do not publish the applicant.

Sites & property

Location & real-estate footprint
Registered office, Bornem · 1 establishment unit since 2023
registered office establishment The establishment unit on the map
Ground area
372 m²
Building footprint
154 m²
Building volume
917 m³
Parcel 12362E0068/00H003, Flanders · tallest building 10.4 m. Linked by address, not a title deed.
1 establishment unit
Perfect Pharma 👍
Sint-Amandsesteenweg(BOR) 212, 2880 BornemRetail sale of pharmaceutical products
since 2023unit no. 2.347.722.672
1 parcel
Flanders 1 (100%)
Cadastral parcel Region Area Buildings Height / floors
12362E0068/00H003 Flanders 372 m² 1 · 154 m² 10.4 m · 2
How the parcels are linked
Good to know
The parcel matches the address exactly.

Articles of association

What the company does

PurposeThe activities the company may carry out under its articles.
“Het oprichten,overnemen en uitbaten van apotheken,aankoop en verkoop,in- en uitvoer,fabricatie in het groot en in het klein van…” (deed in Dutch)
9 activities (deed in Dutch)
  1. Het oprichten,overnemen en uitbaten van apotheken,aankoop en verkoop,in- en uitvoer,fabricatie in het groot en in het klein van scheikundige,farmaceutische en para-farmaceutische artikelen
  2. De handel in kruiden,drogisterij-,parfumerie-,schoonheids-,toilet-,verband-,dieet,laboratorium-,optische en onderhoudsartikelen en aanverwante producten of diensten
  3. Het ondernemen van industriële en klinische ontledingen
  4. Alle mogelijke advies en/of dienstenfuncties op voormelde gebieden
  5. Iedere handelsbedrijvigheid welke met de gezondheidszorg verband houdt,in de ruimste zin genomen
  6. Alle mogelijke advies en/of dienstenfuncties op voormelde gebieden
  7. Consultancy,opleiding,technische expertise en bijstand op voornoemd(e) gebied(en)
  8. Het geven van advies en verstrekken van diensten met betrekking tot de organisatie en het beheer van bedrijven die op die domeinen actief zijn,de vertegenwoordiging en het optreden als commercieel tussenpersoon
  9. Het aanleggen,het oordeelkundig beheer en het uitbreiden van een roerend en onroerend vermogen

The full purpose is in the deed

DurationHow long the company exists; usually unlimited, so until it is dissolved.
Unlimited
Name clauseThe name the company operates under according to its articles.
PHLV
Registered office clauseThe region of the registered office; it decides among other things the language of official documents.
“Vlaams Gewest, bij enkel besluit bestuursorgaan administratieve zetels,agentschappen,werkhuizen,stapelplaatsen,bijkantoren in België of…” (deed in Dutch)

deed of 11-07-2023

Who represents it, and how

Who signsWho may bind the company towards others, for example by signing a contract.
Each director alone
Board ruleHow the board is made up, meets and takes decisions.
“Met of zonder beperking van duur, één of meer” (deed in Dutch)

deed of 11-07-2023

Capital, shares and profit

Transfer restrictionWhether shareholders may sell their shares freely or need approval first.
“Helft overdrager,helft koper(s),naar evenredigheid aantal bij meerdere kopers, elke overdracht onder levenden ten bezwarende of kosteloze…” (deed in Dutch)

deed of 11-07-2023

Meetings and financial year

Annual meetingWhen the shareholders meet each year, among other things to approve the annual accounts.
Third Monday of June at 18:00

deed of 11-07-2023

Oversight and winding up

Statutory auditorA statutory auditor is a registered auditor who checks the accounts; small companies need not have one. According to the deed, the legal criteria do not require one here.
No statutory auditor
Liquidation ruleHow assets are shared after dissolution: creditors first, then shareholders.
“Ontbinding om welke reden en op welk ogenblik ook, bestuurder(s) in functie krachtens statuten indien geen andere vereffenaar benoemd” (deed in Dutch)

deed of 11-07-2023

Other provisionsOther rules from the articles that fall under none of the themes above.

Other provision: “Bestemming van de winst – reserves, algemene vergadering” (deed in Dutch)
Other provision: “Bevoegdheden van het bestuursorgaan, behalve wet of statuten aan algemene vergadering voorbehouden” (deed in Dutch)
Other provision: “Toegang algemene vergadering, ingeschreven houder effecten op naam in register per categorie” (deed in Dutch)
Other provision: “Bestuurder, bij gebrek aandeelhouder met meeste aandelen, bij pariteit oudste, zittingen proces-verbaal” (deed in Dutch)
Other provision: “Bestuursorgaan tijdens zitting, verdaging algemene vergadering” (deed in Dutch)
5 more provisions in the deed, see the deed of 11-07-2023

deed of 11-07-2023